Table 1.
Participant characteristics.
| IMX (n = 54) | DEL (n = 50) | P value | |
|---|---|---|---|
| Age, year | 69.0 ± 6.3 | 67.5 ± 7.7 | 0.266 |
| Height, cm | 173.4 ± 7.1 | 172.7 ± 6.2 | 0.602 |
| Weight, kg | 82.9 ± 16.4 | 84.6 ± 12.9 | 0.551 |
| BMI, kg/m2 | 27.5 ± 4.4 | 28.3 ± 3.9 | 0.282 |
| Body fat (%) | 29.0 ± 5.1 | 30.4 ± 5.2 | 0.159 |
| Married, N (%) | 42 (77.8) | 41 (82.0) | 0.914 |
| Currently employed, N (%) | 13 (24.1) | 17 (34.0) | 0.264 |
| Tertiary education, N (%) | 13 (24.1) | 11 (22.0) | 0.802 |
| Current smoker, N (%) | 5 (9.3) | 3 (6.0) | 0.533 |
| Number of medications | 3.0 (2.0–5.0) | 3.0 (2.0–5.3) | 0.715 |
| Godin LSI, median (IQR) | 10.0 (0.0–24.5) | 10.0 (0.0–27.0) | 0.872 |
| Gleason score | 7.6 ± 1.0 | 7.6 ± 0.8 | 0.829 |
| PSA, ng/mL median (IQR) | 3.4 (0.7–6.4) | 3.9 (0.2–10.0) | 0.599 |
| Testosterone, nmol/L median (IQR) | 8.0 (2.0–16.0) | 4.6 (1.9–15.8) | 0.413 |
| Time since ADT injection (days) | 6.4 ± 2.1 | 5.7 ± 1.9 | 0.110 |
| Prostatectomy, N (%) | 15 (27.7) | 17 (34.0) | 0.532 |
| Radiation, N (%) | 4 (7.4) | 3 (6.0) | 0.775 |
| Number of comorbiditiesa | 1.0 (1.0–2.0) | 1.5 (1.0–2.0) | 0.646 |
Values are the mean ± SD unless stated otherwise.
IMX immediate exercise, DEL delayed exercise, BMI body mass index, LSI Leisure Score Index with a moderate-to-strenuous LSI ≥ 24 classed as active and ≤23 classed as insufficiently active, PSA prostate-specific antigen, ADT androgen deprivation therapy, IQR interquartile range.
aCardiovascular disease, hypertension, diabetes and dyslipidaemia.